Holger Richly

Head of Laboratory Biologicals Development / Molecular Biology at Boehringer Ingelheim Pharma GmbH & Co. KG

Holger Richly currently works as an Associate Director and Lab Head on the development of manufacturing CHO cell lines at Boehringer Ingelheim in Biberach. Besides, he contributes to several projects involving NGS technologies and molecular biology topics like expression vector optimization, (epi)genetic elements and targeted integration. Before, he was working as a research group leader on chromatin biology in the realms of DNA repair, Aging and Stem Cell Differentiation. Holger holds a PhD in Biology from the University of Munich (Germany).